Regulator cracks down on medical price gouging

BEIJING: Market supervision and law enforcement have been enhanced to ensure the stable pricing and quality of epidemic-related drugs and materials, according to the State Administration for Market Regulation.
With the relaxation of COVID-19 prevention and control policies in December, demand for drugs and other materials related to the epidemic has skyrocketed.
To ensure that prices remain stable and that only quality products are available on the market, and to deter illegal activities aimed at exploiting the increased demand, a series of measures have been put in place to keep such actions in check, according to a recently released SAMR work plan.
The plan calls for the deployment of market regulatory authorities at all levels to engage in a special operation, which will last until the end of June, to ensure the stable price and quality of epidemic drugs and medical supplies.
The operation is a comprehensive effort to mobilize the market regulatory system to tackle illegal activities in the field of drugs and medical supplies related to the epidemic, Luo Wen, head of the SAMR, said at a meeting on Wednesday in Beijing.
He asked the authorities to respond quickly to the changing situation, enforce the law accurately, conduct practical supervision and impose strict punishment on violators.
The document asked market regulatory bodies to comprehensively strengthen supervision and law enforcement, and resolutely crack down on price gouging, fake advertising and on the infringement of intellectual property.
–The Daily Mail-China
Daily news exchange item